高フェニルアラニン血（Hyperphenylalaninemia）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperphenylalaninemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperphenylalaninemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperphenylalaninemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hyperphenylalaninemia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hyperphenylalaninemia Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Teijin Limited 32
Clinical Trial Overview of Teijin Limited 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Sanofi 34
Clinical Trial Overview of Sanofi 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Fuji Yakuhin Co., Ltd. 36
Clinical Trial Overview of Fuji Yakuhin Co., Ltd. 36
BioMarin Pharmaceutical Inc. 37
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 37
Sanwa Kagaku Kenkyusho Co., Ltd. 38
Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 38
Nuon Therapeutics, Inc. 39
Clinical Trial Overview of Nuon Therapeutics, Inc. 39
Japan Tobacco Inc. 40
Clinical Trial Overview of Japan Tobacco Inc. 40
BioCryst Pharmaceuticals, Inc. 41
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Kyushu University 42
Clinical Trial Overview of Kyushu University 42
University of Otago 43
Clinical Trial Overview of University of Otago 43
China Medical University Hospital 44
Clinical Trial Overview of China Medical University Hospital 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
Tottori University Hospital 46
Clinical Trial Overview of Tottori University Hospital 46
Fukushima Medical University 47
Clinical Trial Overview of Fukushima Medical University 47
The University of Texas Health Science Center at Houston 48
Clinical Trial Overview of The University of Texas Health Science Center at Houston 48
The Medical Center Leeuwarden 49
Clinical Trial Overview of The Medical Center Leeuwarden 49
Juntendo University School of Medicine 50
Clinical Trial Overview of Juntendo University School of Medicine 50
Midorigaoka Hospital 51
Clinical Trial Overview of Midorigaoka Hospital 51
Five Key Clinical Profiles 52
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 95